These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6240029)

  • 1. Benefits of reducing--revisited.
    Blackburn GL; Read JL
    Postgrad Med J; 1984; 60 Suppl 3():13-8. PubMed ID: 6240029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benefits of sustained moderate weight loss in obesity.
    Pasanisi F; Contaldo F; de Simone G; Mancini M
    Nutr Metab Cardiovasc Dis; 2001 Dec; 11(6):401-6. PubMed ID: 12055705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The workinghman's diet. II. Effect of weight reduction in obese patients with hypertension, diabetes, hyperuricemia and hyperlipidemia.
    Heyden S
    Nutr Metab; 1978; 22(3):141-59. PubMed ID: 634508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of metabolic syndrome.
    Wagh A; Stone NJ
    Expert Rev Cardiovasc Ther; 2004 Mar; 2(2):213-28. PubMed ID: 15151470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effect of low carbohydrate in low calorie diets on visceral fat reduction in type 2 diabetic patients with obesity.
    Miyashita Y; Koide N; Ohtsuka M; Ozaki H; Itoh Y; Oyama T; Uetake T; Ariga K; Shirai K
    Diabetes Res Clin Pract; 2004 Sep; 65(3):235-41. PubMed ID: 15331203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dietetic-hygienic measures in the control of arterial hypertension in obese females].
    Pecelj-Gec M; Jorga J; Marmut Z; Plećas D; Mirić G
    Srp Arh Celok Lek; 1992; 120(9-10):273-5. PubMed ID: 1306018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome success in obesity.
    Klein S
    Obes Res; 2001 Nov; 9 Suppl 4():354S-358S. PubMed ID: 11707565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of diabetes in patients with severe obesity.
    Scheen AJ
    Biomed Pharmacother; 2000 Mar; 54(2):74-9. PubMed ID: 10759290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of very-low-calorie diets in the treatment of obese persons with non-insulin-dependent diabetes mellitus.
    Wing RR
    J Am Diet Assoc; 1995 May; 95(5):569-72; quiz 573-4. PubMed ID: 7722192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Non-pharmacological therapy of metabolic syndrome].
    Wirth A
    Herz; 1995 Feb; 20(1):56-69. PubMed ID: 7713478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. X-PERT: weight reduction with orlistat in obese subjects receiving a mildly or moderately reduced-energy diet: early response to treatment predicts weight maintenance.
    Toplak H; Ziegler O; Keller U; Hamann A; Godin C; Wittert G; Zanella MT; Zúñiga-Guajardo S; Van Gaal L
    Diabetes Obes Metab; 2005 Nov; 7(6):699-708. PubMed ID: 16219013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High protein diets decrease total and abdominal fat and improve CVD risk profile in overweight and obese men and women with elevated triacylglycerol.
    Clifton PM; Bastiaans K; Keogh JB
    Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):548-54. PubMed ID: 19179060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of low energy diet and weight loss on major risk factors, central obesity and associated disturbances in patients with essential hypertension.
    Singh RB; Niaz MA; Bishnoi I; Singh U; Begum R; Rastogi SS
    J Hum Hypertens; 1995 May; 9(5):355-62. PubMed ID: 7623373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Very-low-calorie-diets: is there a place for them in the management of the obese diabetic?].
    Monnier L; Colette C; Percheron C; Boniface H
    Diabetes Metab; 2000 Jun; 26 Suppl 3():46-51. PubMed ID: 10945153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cardiovascular risk factors and prevention in women: similarities and differences].
    Sclavo M
    Ital Heart J Suppl; 2001 Feb; 2(2):125-41. PubMed ID: 11255880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of orlistat on weight regain and cardiovascular risk factors following a very-low-energy diet in abdominally obese patients: a 3-year randomized, placebo-controlled study.
    Richelsen B; Tonstad S; Rössner S; Toubro S; Niskanen L; Madsbad S; Mustajoki P; Rissanen A
    Diabetes Care; 2007 Jan; 30(1):27-32. PubMed ID: 17192328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment modalities of obesity: what fits whom?
    Hainer V; Toplak H; Mitrakou A
    Diabetes Care; 2008 Feb; 31 Suppl 2():S269-77. PubMed ID: 18227496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of sibutramine in 2225 subjects with cardiovascular risk factors: short-term, open-label, observational study.
    Gaciong Z; Placha G
    J Hum Hypertens; 2005 Sep; 19(9):737-43. PubMed ID: 15905888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of short-term hypocaloric diet on sympatho-vagal interaction assessed by spectral analysis of heart rate and blood pressure variability during stress tests in obese hypertensive patients.
    Ashida T; Ono C; Sugiyama T
    Hypertens Res; 2007 Dec; 30(12):1199-203. PubMed ID: 18344625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Weight management for type 2 diabetes mellitus: global cardiovascular risk reduction.
    Lee M; Aronne LJ
    Am J Cardiol; 2007 Feb; 99(4A):68B-79B. PubMed ID: 17307059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.